Zobrazeno 1 - 10
of 13
pro vyhledávání: '"L J, Foshag"'
Publikováno v:
Cancer research. 61(15)
Multiple genetic alterations including loss of heterozygosity (LOH) occur commonly in melanoma tumors. We demonstrated previously free-circulating DNA microsatellites with LOH in the blood of melanoma patients. These LOH markers in plasma may be usef
Autor:
T F, Wood, G J, Tsioulias, D L, Morton, D, Rangel, W, Hutchinson, L J, Foshag, R R, Turner, A J, Bilchik
Publikováno v:
The American surgeon. 66(11)
Approximately 30 per cent of patients with early colorectal carcinoma (CRC) develop systemic disease. A subgroup of these patients may harbor occult micrometastatic disease and might benefit from adjuvant chemotherapy. We investigated sentinel lymph
Publikováno v:
Cancer. 85(10)
This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chro
Autor:
A J, Bilchik, A, Giuliano, R, Essner, P, Bostick, P, Kelemen, L J, Foshag, S, Sostrin, R R, Turner, D L, Morton
Publikováno v:
The cancer journal from Scientific American. 4(6)
Regional lymph node involvement is the most important prognostic indicator in patients with solid tumors. Conventional lymph node dissection has not been shown to affect survival and is often associated with considerable morbidity. Intraoperative lym
Publikováno v:
Cancer research. 54(13)
Patients with melanoma metastatic to distant sites or at high risk for recurrent melanoma have been treated with a polyvalent melanoma cell vaccine (MCV) in phase II protocols. We assessed in vivo and in vitro cell-mediated responses to MCV in 163 pa
Publikováno v:
Cancer. 72(3)
The authors have demonstrated that immunization with melanoma whole-cell vaccine (MCV) augments T-cell responses to melanoma and that cytotoxic T-cells (CTL) recognize allogeneic melanoma-bearing shared HLA-A antigens. A preclinical model was develop
Publikováno v:
Cancer. 71(11)
The American Joint Committee on Cancer (AJCC) uses both Breslow thickness and Clark level in its staging system for malignant melanoma. Stage I corresponds to Breslow thicknesses less than 1.5 mm and Clark levels II and III. Stage II corresponds to B
Publikováno v:
Surgery. 113(4)
Between 1971 and 1989, 144 patients underwent 183 surgical procedures for resection of nonregional metastatic melanoma.Thirty-six patients with subcutaneous or nodal metastases, 46 patients with pulmonary metastases, 17 patients with brain metastases
Publikováno v:
Cancer research. 52(21)
The expression of the interleukin 4 (IL-4) receptor (IL-4R) and effects of human recombinant IL-4 on human gastric carcinoma cell lines were studied. We demonstrated that IL-4 inhibited the growth of gastric carcinoma cells in a dose dependent manner
Publikováno v:
Cancer research. 50(17)
Previous studies have shown that melanoma patients develop an immune response to cell surface melanoma-associated antigens. The presence of this antibody response to cell surface antigens has been correlated with a better clinical outcome when melano